Back to Journals » Clinical Ophthalmology » Volume 13

Timing of neovascular regression in eyes with high-risk proliferative diabetic retinopathy without macular edema treated initially with intravitreous bevacizumab

Total article views   HTML views PDF downloads Totals
9,699 Dovepress* 7,831+ 1,602 9,433
PubMed Central* 1,868 245 2,113
Totals 9,699 1,847 11,546
*Since 19 December 2018
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar